Numerical data points underlying presented graphs. by Luke R. Joyce (12107297)

Network architectures for single-agent task. by Hongjie Zhang (136127)

Network architectures for multi-agents task. by Hongjie Zhang (136127)

“…Subsequently, we establish optimization objectives for single-agent and multi-agents inference, incorporating cost constraints based on the IMPALA and MAPPO frameworks, respectively. …”

Plant growth, nodulation, and N content as affected by manipulating of GmNN1/FT2a. by Xinxin Li (281237)

Expression of <i>GmNN1/FT2a</i> in various tissues of soybean plants. by Xinxin Li (281237)

GmNN1/FT2a interacted with GmNYFA-C in the BiFC assay. by Xinxin Li (281237)

Process of simulating and predicting the rural population changes using agent-based modeling. by Shanshan Huang (2030734)

Subjects:

Discovery of the Next-Generation Platinum-Based Anticancer Agents for Combating Oxaliplatin-Induced Drug Resistance by Ziru Sun (18781632)

Subjects:

Change in the levels of parental stressors or rewards between time point 1 and time point 2. by Ragnhild Bjørknes (4908577)

Subjects:

Structure of the principal-agent base model of cold chain service of fresh produce supply chain. by Ming Zeng (189146)

Patient demographic information at four time points. by Ruitian Song (11045127)

Subjects:

Tumor ratios based on SPECT imaging of francium-221 and bismuth-213. by Yong Du (86188)

Multicolorimetric Sensor Array Based on Silver Metallization of Gold Nanorods for Discriminating Dopaminergic Agents by Reza Koohsar (19442973)

Subjects:

Gene specific primers used for <i>GmNN1/FT2a</i> fine mapping. by Xinxin Li (281237)

Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. by Melinda H. Spooner (6551933)

“…The figure illustrates the earliest time point for a significant change in the marker abundance and whether the marker <b>Increased</b> or <b>Decreased</b> in response to the WD. …”

Significant differences between Th17-cell levels of dogs suffering from IVDH at all three sampling time points and in comparison with the healthy control group. by Annika Kämpe (11507012)

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

Shows 48/86 genes have differential expression consistent with the direction of decrease in cell movement. by Afrooz Jahedi (14636554)

Functional relationship between agent effort and probability of conducting an experiment. by Ben G. Fitzpatrick (18569859)